| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 104, 409-418, Copyright © 1979 by Endocrine Society
ARTICLES |
BK Vonderhaar and AE Greco
The mammary glands of euthyroid female C3H/HeN mice undergo a series of morphological changes during development. In glands from immature animals, the epithelial component consists of a sparse ductal system with few branches which fills about one fourth of the fat pad. In the adult virgin gland, the epithelial component fills the fat pad with a highly branched ductal system and a few alveoli. In contrast, glands from adult animals maintained in a hypothyroid state by ingestion of thiouracil since weaning retain the primitive ductal appearance while filling the fat pad. The glands from animals made hyperthroid by adding 2 micrograms T4/ml drinking water have extensive lobulo-alveolar development. Glands from animals made hypothyroid during 7 weeks of involution after lactation have the same degree of deveopment as the euthyroid controls. When explants of tissue from adult hypothyroid virgin animals are cultured in serum-free medium containing insulin, hydrocortisone, and PRL, the specific milk protein, alpha-lactalbumin, is induced. The level of alpha-lactalbumin, measured as lactose synthetase activity, found per ng epithelial DNA is the same as that found in explants from glands of euthyroid virgins. These results suggest that thyroid hormones, in concert with PRL, play an important role in the regulation of development of the mouse mammary gland. Decreased levels of thyroid hormones in the serum result in retarded growth of the ductal system and little or no alveolar development. However, the resulting epithelial component of glands from hypothyroid mice is fully capable of differentiating in vitro when exposed to the proper hormonal environment.
This article has been cited by other articles:
![]() |
B. Schade, S. H.L. Lam, D. Cernea, V. Sanguin-Gendreau, R. D. Cardiff, B. L. Jung, M. Hallett, and W. J. Muller Distinct ErbB-2 Coupled Signaling Pathways Promote Mammary Tumors with Unique Pathologic and Transcriptional Profiles Cancer Res., August 15, 2007; 67(16): 7579 - 7588. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Conde, R. Paniagua, J. Zamora, M. J. Blanquez, B. Fraile, A. Ruiz, and M. I. Arenas Influence of thyroid hormone receptors on breast cancer cell proliferation Ann. Onc., January 1, 2006; 17(1): 60 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Siegel, W. Shu, R. D. Cardiff, W. J. Muller, and J. Massague Transforming growth factor {beta} signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis PNAS, July 8, 2003; 100(14): 8430 - 8435. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Song and T. Oka Regulation of type II deiodinase expression by EGF and glucocorticoid in HC11 mouse mammary epithelium Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1119 - E1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Simon, M.-T. C. Tang, L. Bernstein, S. A. Norman, L. Weiss, R. T. Burkman, J. R. Daling, D. Deapen, S. G. Folger, K. Malone, et al. Do Thyroid Disorders Increase the Risk of Breast Cancer? Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1574 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dankort, B. Maslikowski, N. Warner, N. Kanno, H. Kim, Z. Wang, M. F. Moran, R. G. Oshima, R. D. Cardiff, and W. J. Muller Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast Cancer Mol. Cell. Biol., March 1, 2001; 21(5): 1540 - 1551. [Abstract] [Full Text] |
||||
![]() |
C. F. Ramos, C. V. Teixeira, M. C. F. Passos, C. C. Pazos-Moura, P. C. Lisboa, F. H. Curty, and E. G. de Moura Low-Protein Diet Changes Thyroid Function in Lactating Rats Experimental Biology and Medicine, September 1, 2000; 224(4): 256 - 263. [Abstract] [Full Text] |
||||
![]() |
T. M. Casey, A. Boecker, J.-F. Chiu, and K. Plaut Glucocorticoids Maintain the Extracellular Matrix of Differentiated Mammary Tissue During Explant and Whole Organ Culture Experimental Biology and Medicine, June 1, 2000; 224(2): 76 - 86. [Abstract] [Full Text] |
||||
![]() |
M. J. Rauh, V. Blackmore, E. R. Andrechek, C. G. Tortorice, R. Daly, V. K.-M. Lai, T. Pawson, R. D. Cardiff, P. M. Siegel, and W. J. Muller Accelerated Mammary Tumor Development in Mutant Polyomavirus Middle T Transgenic Mice Expressing Elevated Levels of Either the Shc or Grb2 Adapter Protein Mol. Cell. Biol., December 1, 1999; 19(12): 8169 - 8179. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Murphy, R. G. Schnall, D. J. Venter, L. Barnett, I. Bertoncello, C. B. F. Thien, W. Y. Langdon, and D. D. L. Bowtell Tissue Hyperplasia and Enhanced T-Cell Signalling via ZAP-70 in c-Cbl-Deficient Mice Mol. Cell. Biol., August 1, 1998; 18(8): 4872 - 4882. [Abstract] [Full Text] |
||||
![]() |
E. R. Andrechek, W. R. Hardy, P. M. Siegel, M. A. Rudnicki, R. D. Cardiff, and W. J. Muller Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis PNAS, March 28, 2000; 97(7): 3444 - 3449. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |